PCD Pharma Franchise Opportunities in Andaman and Nicobar with Daksh Diabetes and Cardiac Care

Recent health data reveals that lifestyle diseases, particularly diabetes and hypertension, are emerging as significant health challenges in the Andaman and Nicobar Islands. As a Union Territory with a unique geographic and demographic profile, the islands face a distinct set of healthcare challenges. The population of approximately 4.5 lakh is spread across numerous islands, with a mix of indigenous communities and settlers from mainland India. According to the National Family Health Survey, the prevalence of diabetes and hypertension in the Andaman and Nicobar Islands has been showing an increasing trend, mirroring the national pattern of rising non-communicable diseases.

While specific prevalence data for the Union Territory is limited, the overall national trends indicate a worrying picture. A community-based study in the Andaman and Nicobar Islands found that the prevalence of diabetes was higher than the national average. The primary drivers include dietary shifts away from traditional fish and rice-based diets towards more processed foods, combined with sedentary occupationsstressful living, and declining physical activity, all contributing to poor blood sugar regulation and awareness gaps in self-care practices.

The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockagesheart attacksstrokes, and nerve damage (neuropathy) that affects heart rate regulationAdults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers families in the Andaman and Nicobar Islands through regular screeningmedication adherencelifestyle modifications, and early detection – ensuring thousands become success stories of integrated care and better health outcomes.

How Daksh is making a Difference in Andaman and Nicobar Islands

1. Affordable, Quality-Assured Medications

Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment.

What this means for Andaman and Nicobar Islands patients:

  • Access to WHO-GMP certified medications
  • Lower out-of-pocket expenses for lifelong treatments
  • No compromise on quality despite affordable pricing

2. Complete Cardiac Care Portfolio

Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs:

Product CategoryDaksh OfferingsPurpose
ACE InhibitorsDORAPIL (Ramipril)Blood pressure control, heart failure treatment
ARBsCARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan)Hypertension management
Beta-BlockersCARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol)Heart rate control, heart failure
Calcium Channel BlockersDUPIN (Amlodipine), CLINITAC (Cilnidipine)Blood pressure, angina
DiureticsTORDAC (Torsemide), FRUSIDIPFluid management in heart failure
Lipid ManagementROSADAC (Rosuvastatin), ATRODAC (Atorvastatin)Cholesterol control

3. Complete Diabetic Care Portfolio

For diabetes management, Daksh provides modern therapeutic options including:

Product CategoryDaksh Offerings
SGLT2 InhibitorsDYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug
DPP-4 InhibitorsTENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin)
SulfonylureasGLIMIDAC (Glimepiride)
BiguanidesGLYCODIP SR (Metformin)
Combination TherapiesDYFOZIN M, GLIMIDAC MV (triple combination)

4. Focus on Preventive Care

Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications:

  • Liver tonics for medication-induced liver protection
  • Calcium supplements for bone health (critical for diabetic patients)
  • Vitamin complexes for overall metabolic support

5. Supporting Healthcare Providers across the Islands

Daksh works with hospitals, clinics, and pharmacies across the Andaman and Nicobar Islands to ensure that quality medications reach every corner of the Union Territory. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses.

With the growing disease burden and limited competition, there is immense potential to build a meaningful healthcare business while serving your community.

Conclusion

The diabetes and heart disease burden in the Andaman and Nicobar Islands is not just a statistic it is a reality affecting thousands of families. With the rising prevalence of diabetes and hypertension, limited healthcare access, and low competition, there is an urgent need for quality medications and healthcare services. But there is hope. With the right medicationsproper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives.

Daksh Diabetic & Cardiac Care is committed to being part of this solution providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines.

Contact Daksh Diabetic and Cardiac

Contact MethodDetails
Office AddressPlot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India
Phone📞 +91 93565 60523 📞 +91 78886 02869
Emailenquirypurchase.daksh@gmail.com
Contact ushttps://diabetes-cardiac.com/contact-us/